Omar K Siddiqi1, Musie Ghebremichael2, Xin Dang3, Masharip Atadzhanov4, Patrick Kaonga4, Michael N Khoury3, Igor J Koralnik3. 1. Division of Neuro-Virology, Beth Israel Deaconess Medical Center, Boston, Massachusetts Department of Internal Medicine, University of Zambia School of Medicine, Lusaka. 2. Harvard Medical School and Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Boston. 3. Division of Neuro-Virology, Beth Israel Deaconess Medical Center, Boston, Massachusetts. 4. Department of Internal Medicine, University of Zambia School of Medicine, Lusaka.
Abstract
BACKGROUND: Knowledge of central nervous system (CNS) opportunistic infections (OIs) among people living with human immunodeficiency virus (HIV) in sub-Saharan Africa is limited. METHODS: We analyzed 1 cerebrospinal fluid (CSF) sample from each of 331 HIV-infected adults with symptoms suggestive of CNS OI at a tertiary care center in Zambia. We used pathogen-specific primers to detect DNA from JC virus (JCV), varicella zoster virus (VZV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), herpes simplex virus (HSV) types 1 and 2, Mycobacterium tuberculosis, and Toxoplasma gondii via real-time polymerase chain reaction (PCR). RESULTS: The patients' median CD4(+) T-cell count was 89 cells/µL (interquartile range, 38-191 cells/µL). Of 331 CSF samples, 189 (57.1%) had at least 1 pathogen. PCR detected DNA from EBV in 91 (27.5%) patients, M. tuberculosis in 48 (14.5%), JCV in 20 (6.0%), CMV in 20 (6.0%), VZV in 13 (3.9%), HSV-1 in 5 (1.5%), and HSV-2 and T. gondii in none. Fungal and bacteriological studies showed Cryptococcus in 64 (19.5%) patients, pneumococcus in 8 (2.4%), and meningococcus in 2 (0.6%). Multiple pathogens were found in 68 of 189 (36.0%) samples. One hundred seventeen of 331 (35.3%) inpatients died during their hospitalization. Men were older than women (median, 37 vs 34 years; P = .01), more recently diagnosed with HIV (median, 30 vs 63 days; P = .03), and tended to have a higher mortality rate (40.2% vs 30.2%; P = .07). CONCLUSIONS: CNS OIs are frequent, potentially treatable complications of AIDS in Zambia. Multiple pathogens often coexist in CSF. EBV is the most prevalent CNS organism in isolation and in coinfection. Whether it is associated with CNS disease or a marker of inflammation requires further investigation. More comprehensive testing for CNS pathogens could improve treatment and patient outcomes in Zambia.
BACKGROUND: Knowledge of central nervous system (CNS) opportunistic infections (OIs) among people living with human immunodeficiency virus (HIV) in sub-Saharan Africa is limited. METHODS: We analyzed 1 cerebrospinal fluid (CSF) sample from each of 331 HIV-infected adults with symptoms suggestive of CNS OI at a tertiary care center in Zambia. We used pathogen-specific primers to detect DNA from JC virus (JCV), varicella zoster virus (VZV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), herpes simplex virus (HSV) types 1 and 2, Mycobacterium tuberculosis, and Toxoplasma gondii via real-time polymerase chain reaction (PCR). RESULTS: The patients' median CD4(+) T-cell count was 89 cells/µL (interquartile range, 38-191 cells/µL). Of 331 CSF samples, 189 (57.1%) had at least 1 pathogen. PCR detected DNA from EBV in 91 (27.5%) patients, M. tuberculosis in 48 (14.5%), JCV in 20 (6.0%), CMV in 20 (6.0%), VZV in 13 (3.9%), HSV-1 in 5 (1.5%), and HSV-2 and T. gondii in none. Fungal and bacteriological studies showed Cryptococcus in 64 (19.5%) patients, pneumococcus in 8 (2.4%), and meningococcus in 2 (0.6%). Multiple pathogens were found in 68 of 189 (36.0%) samples. One hundred seventeen of 331 (35.3%) inpatients died during their hospitalization. Men were older than women (median, 37 vs 34 years; P = .01), more recently diagnosed with HIV (median, 30 vs 63 days; P = .03), and tended to have a higher mortality rate (40.2% vs 30.2%; P = .07). CONCLUSIONS: CNS OIs are frequent, potentially treatable complications of AIDS in Zambia. Multiple pathogens often coexist in CSF. EBV is the most prevalent CNS organism in isolation and in coinfection. Whether it is associated with CNS disease or a marker of inflammation requires further investigation. More comprehensive testing for CNS pathogens could improve treatment and patient outcomes in Zambia.
Authors: Rafael T Mesquita; Ângela P Ziegler; Roberto M Hiramoto; Jose E Vidal; Vera L Pereira-Chioccola Journal: J Med Microbiol Date: 2010-02-11 Impact factor: 2.472
Authors: A Zumla; D Savva; R B Wheeler; S K Hira; N P Luo; P Kaleebu; S K Sempala; J D Johnson; R Holliman Journal: Trans R Soc Trop Med Hyg Date: 1991 Mar-Apr Impact factor: 2.184
Authors: Christian Manzardo; María Del Mar Ortega; Omar Sued; Felipe García; Asunción Moreno; José M Miró Journal: J Neurovirol Date: 2005 Impact factor: 2.643
Authors: Matthew J Kelly; Laura A Benjamin; Katharine Cartwright; Katherine M B Ajdukiewicz; Danielle B Cohen; Mavis Menyere; Sareen Galbraith; Malcolm Guiver; Florian Neuhann; Tom Solomon; David G Lalloo; Robert S Heyderman Journal: J Infect Dis Date: 2011-11-09 Impact factor: 5.226
Authors: Omar K Siddiqi; Melissa A Elafros; Christopher M Bositis; Igor J Koralnik; William H Theodore; Jason F Okulicz; Lisa Kalungwana; Michael J Potchen; Izukanji Sikazwe; Gretchen L Birbeck Journal: Neurology Date: 2016-12-21 Impact factor: 9.910
Authors: Omar K Siddiqi; Melissa A Elafros; Izukanji Sikazwe; Gretchen L Birbeck; Lisa Kalungwana; Michael J Potchen; Christopher M Bositis; Igor J Koralnik; William H Theodore Journal: Neurology Date: 2015-03-04 Impact factor: 9.910
Authors: Kiran T Thakur; Alexandra Boubour; Deanna Saylor; Mitashee Das; David R Bearden; Gretchen L Birbeck Journal: AIDS Date: 2019-02-01 Impact factor: 4.177
Authors: Poornima Ramanan; Alexandra L Bryson; Matthew J Binnicker; Bobbi S Pritt; Robin Patel Journal: Clin Microbiol Rev Date: 2017-11-15 Impact factor: 26.132
Authors: Radha Rajasingham; Rachel M Smith; Benjamin J Park; Joseph N Jarvis; Nelesh P Govender; Tom M Chiller; David W Denning; Angela Loyse; David R Boulware Journal: Lancet Infect Dis Date: 2017-05-05 Impact factor: 25.071
Authors: Joshua Rhein; Nathan C Bahr; Andrew C Hemmert; Joann L Cloud; Satya Bellamkonda; Cody Oswald; Eric Lo; Henry Nabeta; Reuben Kiggundu; Andrew Akampurira; Abdu Musubire; Darlisha A Williams; David B Meya; David R Boulware Journal: Diagn Microbiol Infect Dis Date: 2015-12-01 Impact factor: 2.803
Authors: Japheth A Opintan; Benedict K Awadzi; Isaac J K Biney; Vincent Ganu; Richard Doe; Ernest Kenu; Rita F Adu; Mary M Osei; Amos Akumwena; Michael E Grigg; Gary A Fahle; Mercy J Newman; Peter R Williamson; Margaret Lartey Journal: Trans R Soc Trop Med Hyg Date: 2017-10-01 Impact factor: 2.184